Cempra, Inc. To Present At The 21st Annual Future Leaders In The Biotech Industry Conference And Needham & Co. 12th Annual Healthcare
3/21/2014 8:47:08 AM
CHAPEL HILL, N.C., March 20, 2014 (GLOBE NEWSWIRE) -- Cempra, Inc. (Nasdaq:CEMP) today announced that Prabhavathi Fernandes, Ph.D., chief executive officer of Cempra, will present at The 21st Annual Future Leaders in the Biotech Industry Conference at 11:30 a.m. EDT, Friday, March 28, at the Millennium Broadway Hotel & Conference Center in New York City and at the Needham & Co. 12th Annual Healthcare Conference at 12:50 p.m. EDT, Wednesday, April 9, at The Westin New York Grand Central in New York City. Dr. Fernandes will discuss the company's two differentiated antibiotics, solithromycin (CEM-101) for community-acquired bacterial pneumonia and TAKSTA (CEM-102 or fusidic acid) for the chronic, oral treatment of Gram-positive pathogens including methicillin-resistant S. aureus (MRSA) in prosthetic joint infections.
Help employers find you! Check out all the jobs and post your resume.
comments powered by